Bacterial biofilms cause implant failures, chronic inflammation, and immune polarization. The study investigates the possible role of bacterial biofilm as a factor in the etiology of Breast Implant Illness. Three patient cohorts will be studied (A) Subjects with breast implant with BII manifestations (B) Subjects with breast implants without BII manifestations (C) Subjects without breast implants who underwent breast surgery procedure. Blood, surgically discarded tissue, implants, and associated capsules will be collected through this protocol.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Presence of Biofilm in Breast Tissue
Timeframe: Through study completion, an average of 1 year
Analysis of host-biofilm interaction mediated oxylipins from blood
Timeframe: Through study completion, an average of 1 year
Cytokine analysis will be performed on breast tissue
Timeframe: Through study completion, an average of 1 year
Analysis of host-biofilm interaction mediated oxylipins from breast tissue
Timeframe: Through study completion, an average of 1 year